Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis

By sjmartinez • April 4, 2023

Rastogi A, Fishbane S, Lerma E. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis. Expert Rev Clin Pharmacol. 2023 Apr 3. doi: 10.1080/17512433.2023.2197209. Epub ahead of print. PMID: 37010031.

Tags: Chronic kidney disease, chronic kidney disease-associated pruritus, difelikefalin, efficacy, kappa opioid receptor, Nephrology, opioids, pruritus, Publications, safety

Online hemodiafiltration for kidney failure: guidance and best clinical practice recommendations from the Italian Society of Nephrology

Strippoli GFM, Pellegrino G, Hegbrant J, Fabbrini P, Lentini PLM, Aucella F, Panichi V, Gallieni M, Canaud B, Davenport A, Ortiz A, Ramos R, Malyszko[...]

A literature review and reflection on clinical trials: current challenges, future directions, and potential strategies to overcome practical barriers

Zhang K, Lampridis S, Simone CB 2nd, Negoi I, Peng Y, Shang B, Lin Y, Cheng Y, Yang F, Shelat VG, Kalantar-Zadeh K. A literature[...]

Seizure-Induced Rhabdomyolysis Complicated by Acute Kidney Injury: A Case Report

Kaur H, Kennedy HH, Nobakht N. Seizure-Induced Rhabdomyolysis Complicated by Acute Kidney Injury: A Case Report. Am J Case Rep. 2026 Aug 18;27:e951097. doi: 10.12659/AJCR.951097.[...]